• Sector

    Healthcare

  • Status

    Bulletin

RISK WARNING: Your capital is at risk. The risks of investing include: illiquidity; lack of dividends; loss of investment; and dilution. You should invest only as part of a diversified portfolio.
Please read FULL risk warning

Ceryx Medical

Developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called CPGs.

Track
Contact
Companies
House
Twitter

Overview

Ceryx Medical have developed a revolutionary new microchip technology which is creating a new generation of medical devices for the 21st century.  Ceryx will supply their chip technology to the medical device industry for incorporation into their existing devices.  The technology massively enhances the capabilities of these devices creating new therapies with unprecedented therapeutic effect.  Ceryx’s chip technology could impact multiple diseases, already we have demonstrated that by inserting our chips into a standard cardiac pacemaker we create a curative therapy for heart failure, a disease which affects 20 million people in the US and EU and is currently incurable.

Deal Manager avatar

Contact
Christopher Hill

WE ARE LOOKING FOR:

  • Funding – currently raising £1,000,000
  • NED/Chairman with experience in cardiac rhythm management industry
  • Expertise in class III medical device development – particularly project management

Team

This section is currently locked.
Please Sign Up or Log In to unlock.

Market

This section is currently locked.
Please Sign Up or Log In to unlock.

Investment

This section is currently locked.
Please Sign Up or Log In to unlock.

Discussions

This section is currently locked.
Please Sign Up or Log In to unlock.

Originator


Originator: SETsquared Partnership

Investment Focus: Equity

About: The SETsquared Partnership is the enterprise collaboration between the universities of Bath, Bristol, Exeter, Southampton and Surrey.

Contact Name: Jake Ronay

  • Registered Investors
    100 - 250
  • Investment through platform
    Up to £1m